General Information of the Compound
Compound ID
CP0959344
Compound Name
(3S)-4-[[(2S)-1-[2-[[(1R,7S,10S,13S,16S,22S,28R,40R,46S,49S,58S,61S,64S)-13-(2-amino-2-oxoethyl)-28-[[(2S)-1-amino-1-oxopropan-2-yl]carbamoyl]-61-benzyl-16-(3-carbamimidamidopropyl)-49,64-bis(1H-indol-3-ylmethyl)-2,8,11,14,17,23,26,41,47,50,53,59,62,65-tetradecaoxo-10-propan-2-yl-30,38,68-trithia-3,9,12,15,18,24,27,42,48,51,54,60,63,66-tetradecazaheptacyclo[32.32.3.132,36.03,7.018,22.042,46.054,58]heptaconta-32,34,36(70)-trien-40-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-3-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoic acid
    Show/Hide
Structure
Formula
C114H152N30O24S3
Molecular Weight
2422.857
Canonical SMILES
CC(C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H]2CSCc3cc(cc(c3)CSC[C@H](NC(=O)C3CCCN3C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc3c[nH]cn3)NC(=O)[C@H](C)N)C(C)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N2)CSC[C@@H](C(=O)N[C@@H](C)C(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC1=O
    Show/Hide
InChI
InChI=1S/C114H152N30O24S3/c1-59(2)93-109(164)135-79(45-89(116)145)101(156)129-74(26-14-32-121-114(118)119)110(165)141-34-16-27-84(141)104(159)124-50-90(146)128-81(103(158)127-62(6)95(117)150)55-169-52-64-38-65-40-66(39-64)54-171-57-83(137-107(162)87-30-19-37-144(87)113(168)94(60(3)4)139-102(157)80(46-92(148)149)132-100(155)78(130-96(151)61(5)115)44-69-49-120-58-126-69)112(167)142-35-17-29-86(142)106(161)134-76(42-67-47-122-72-24-12-10-22-70(67)72)97(152)125-51-91(147)140-33-15-28-85(140)105(160)133-75(41-63-20-8-7-9-21-63)98(153)131-77(43-68-48-123-73-25-13-11-23-71(68)73)99(154)136-82(56-170-53-65)111(166)143-36-18-31-88(143)108(163)138-93/h7-13,20-25,38-40,47-49,58-62,74-88,93-94,122-123H,14-19,26-37,41-46,50-57,115H2,1-6H3,(H2,116,145)(H2,117,150)(H,120,126)(H,124,159)(H,125,152)(H,127,158)(H,128,146)(H,129,156)(H,130,151)(H,131,153)(H,132,155)(H,133,160)(H,134,161)(H,135,164)(H,136,154)(H,137,162)(H,138,163)(H,139,157)(H,148,149)(H4,118,119,121)/t61-,62-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,87?,88-,93-,94-/m0/s1
    Show/Hide
InChIKey
SFQZXAOPWWKVLL-BJEKBVEWSA-N
Physicochemical Property
logP
-3.66253
Rotatable Bonds
30
Heavy Atom Count
171
Polar Areas
809.71
Hydrogen Bond Donor Count
25
Hydrogen Bond Acceptor Count
29
Complexity
171

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 156016720
ChEMBL ID
CHEMBL4642167
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01335, Ephrin type-A receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 0.54 nM
   TI
   LI
   LO
   TS